A Randomised, Two Way Cross-Over, Single-Blind, Phase I Study to Evaluate 24-hr Glucose Profiles in Patients With T2DM When Dosed OD and BD on Top of Metformin for Four Days With AZD1656.
Phase of Trial: Phase I
Latest Information Update: 09 Dec 2009
At a glance
- Drugs AZD 1656 (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Sponsors AstraZeneca
- 08 May 2009 Actual initiation date (May 2009) added as reported by ClinicalTrials.gov.
- 08 May 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 03 Feb 2009 Actual initiation date (Jan 2009) added as reported by ClinicalTrials.gov.